SavedAdd your journal

Journals / İstanbul Tıp Fakültesi Dergisi / 2021 / Cilt: 84 - Sayı: 2

IMMUN RESPONSES IN COVID-19

COVID-19’DA İMMÜN YANITLAR

Bülent ÇAKAL
Pages
256–263
Publication Date
2021-04-25
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This review aims to examine scientific data about immunopathogenesis of COVID-19

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The Coronavirus disease 19 (COVID-19) pandemic, which is the etiological agent of a severe acute respiratory syndrome- associated coronavirus (SARS-CoV-2), has influenced the whole world with the current and possible results.
📊
Key Findings & Data:COVID-19 has very unique virological, clinical and immunological characteristics.
💡
Conclusion & Impact:This review aims to examine scientific data about immunopathogenesis of COVID-19
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:COVID-19 · SARS-CoV-2 · immünpatoloji

Abstract

The Coronavirus disease 19 (COVID-19) pandemic, which is the etiological agent of a severe acute respiratory syndrome- associated coronavirus (SARS-CoV-2), has influenced the whole world with the current and possible results. COVID-19 has very unique virological, clinical and immunological characteristics. In COVID19, immune responses can vary widely, ranging from responses that allow control of the infection to pulmonary thrombosis characterized by sudden and rapidly developing intense inflammation and storm of cytokenemia. This review aims to examine scientific data about immunopathogenesis of COVID-19

Özet

Şiddetli akut solunum sendromu ilişkili bir coronavirüsün (Severe acute respiratory syndrome-related coronavirus 2; SARS-CoV-2) etiyolojik etkeni olduğu coronavirüs hastalığı 19 (coronavirus disease 19; COVID-19) pandemisi mevcut ve olası sonuçları açısından tüm dünyayı etkisi altına almıştır. COVID-19 oldukça özgün virolojik, klinik ve immünolojik karakteristik özelliklere sahiptir. COVID19’da bağışık yanıtlar enfeksiyonunun kontrol altına alınmasına imkan sağlayan yanıtlardan ani ve hızlı gelişen yoğun enflamasyon ve sitokin fırtınası ile karakterize pulmoner trombozise kadar uzunan geniş bir yelpazede değişkenlik gösterebilmektedir. Bu derlemede COVID-19’un immünpatogenizine ilişkin bilimsel verilerin irdelenmesi amaçlanmıştır.

🔖

Cite This Article

ÇAKAL, B. (2021). IMMUN RESPONSES IN COVID-19. İstanbul Tıp Fakültesi Dergisi, Cilt: 84 - Sayı: 2, 256–263. https://ajindex.com/articles/148173

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Zhou P, Yan X-L, Wang X-G, Hu B, Zhang L, Zhang W. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020
  2. [CrossRef] 2. Gorbalenya AE, Baker SC, Baric RS, Groot RJ, Drosten C, Haagmans BL, et al. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndromerelated coronavirus: classifying. Nat Microbiol 2020
  3. 5(4):536-54. [CrossRef] 3. Liu Y, Ning Z, Chen Y, Guo M, Liu Y, Gali NM. et al. Aerodynamic Characteristics and RNA Concentration of SARS-CoV-2 Aerosol in Wuhan Hospitals during COVID-19 Outbreak. biorRxiv 2020
  4. [CrossRef] 4. Gu J, Han B, Wang J. COVID-19: Gastrointestinal Manifestations and Potential Fecal-Oral Transmission. Gastroenterology 2020
  5. 158(6):1518-19. [CrossRef] 5. Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W. et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. The Lancet 2020
  6. [CrossRef] 6. Guan WJ. Ni, Z-y, Hu Y, Liang W-h, Ou C-q, He J-x. et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020
  7. [CrossRef] 7. Yang J, Zhenga Y, Goua X, Pua K, Chena Z, Guo Q. et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. International Journal of Infectious Diseases 2020
  8. [CrossRef] 8. Chen N, Zhou M, Dong Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020
  9. [CrossRef] 9. Wölfel R, Corman VM, Guggemos W, Seilmaier M, Zange S, Müller MA, et al. Virological assessment of hospitalized patients with COVID-2019. Nature 2020
  10. 581(7809):465-9. [CrossRef] 10. Goyal A, Fabian C-O, E, Schiffer J.T. Potency and timing of antiviral therapy as determinants of duration of SARS CoV-2 shedding and intensity of inflammatory response. MedRxiv 2020
  11. [CrossRef] 11. Chang, Mo G, Yuan X, Tao Y, Peng X, Wang F-S. et al. Time Kinetics of Viral Clearance and Resolution of Symptoms in Novel Coronavirus Infection. Am J Respir Crit Care Med 2020
  12. 201(9):1150-52. [CrossRef] 12. Lin WH, Kouyos RD, Adams RJ, Grenfell BT, Griffin DE. Prolonged persistence of measles virus RNA is characteristic of primary infection dynamics. Proc Natl Acad Sci U S A 2012
  13. 14989-94. [CrossRef] 13. Feng